Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yutaka Hirao is active.

Publication


Featured researches published by Yutaka Hirao.


Vox Sanguinis | 1989

INACTIVATION AND ELIMINATION OF VIRUSES DURING THE FRACTIONATION OF AN INTRAVENOUS IMMUNOGLOBULIN PREPARATION: LIQUID HEAT TREATMENT AND POLYETHYLENE GLYCOL FRACTIONATION

Yahiro Uemura; Katsuhiro Uriyu; Yutaka Hirao; Kazuo Takechi; Hideyuki Ishikawa; Tsunetaka Nakajima; Yoshio Kagitani; Kazumasa Yokoyama; Satoshi Funakoshi; Masayuki Nishida; Sadao Yabushita; Koichi Furuta; Yoshiaki Hamamoto; Tadafumi S. Tochikura; Naoki Yamamoto

Abstract. A method for the heat treatment of human IgG solution at 60 °C for 10 h was established. Human immunodeficiency, mumps, vaccinia and 4 other viruses were added to the IgG solution in 33% sorbitol and heated at 60 °C. Those viruses were inactivated within 1 h. Heat‐treated intravenous IgG (IVIG‐H) was prepared by heat treatment and polyethylene glycol (PEG) fractionation. Conventional nonheated intravenous IgG (IVIG‐C) was prepared from the same source paste by the fractionation method. No physicochemical or biological difference was observed between the heated and control IVIG preparations.


Journal of the Japan Society of Blood Transfusion | 1989

Heat treated intravenous immunoglobulin preparation.

Yahiro Uemura; Kazuo Takechi; Yutaka Hirao; Kazumasa Yokoyama; Masayuki Nishida; Tadakazu Suyama

Before HBsAg screening of plasma was instituted, the preventive effect of immunoglobulin preparations (ISG) against Hepatitis B was not clearly defined. Since HBsAg screening became a requirement, all ISG has shown Anti-HBs and it further became clear that such preparations are effective in preventing Hepatitis B.Recently, cases of Hepatitis NANB associated with administration of intravenous immunoglobulin (IVIG) were reported. Since there is no NANB screening test presently available and IVIG tends to be administered in a large volume, a virus inactivation treatment should be performed on IVIG.Now that heat treatment at 60°C for 10 hours, which had previously been considered to be impossible or unnecessary for immunoglobulin, has become possible, an intravenous immunoglobulin preparation which is more ideal in stability and safety is available.


Archive | 1986

Method of virus-inactivating heat treatment of gamma-globulin

Yutaka Hirao; Katuhiro Uriyu; Yahiro Uemura


Archive | 1990

Production method for protein-containing composition

Shoju Kameyama; Kenmi Miyano; Motonori Hashimoto; Kazuo Takechi; Takao Ohmura; Yutaka Hirao; Yahiro Uemura; Kazumasa Yokoyama


Archive | 1982

Process for heat treatment of aqueous solution containing cold insoluble globulin to inactivate hepatitis virus

Takao Ohmura; Yutaka Hirao; Satoshi Funakoshi


Archive | 1987

Method of producing immunoglobulin preparations for intravenous injection

Yahiro Uemura; Katuhiro Uriyu; Kazuo Takechi; Yutaka Hirao; Tadakazu Suyama


Archive | 1983

Method of lyophilizing cold insoluble globulin

Takao Ohmura; Yutaka Hirao; Takuji Hanamura; Akimasa Ohmizu; Satoshi Funakoshi


Archive | 1998

Immunoglobulin preparation and preparation process thereof

Yutaka Hirao; Motonori Hashimoto; Tae Kitamura; Yahiro Uemura


Archive | 1982

Process for heat treatment of aqueous solution containing cold insoluble globulin

Takao Ohmura; Yutaka Hirao; Satoshi Funakoshi


Archive | 1987

Process for heat treating chemically unmodified gamma-globulin

Yutaka Hirao; Katuhiro Uriyu; Kazuo Takechi; Yahiro Uemura

Collaboration


Dive into the Yutaka Hirao's collaboration.

Top Co-Authors

Avatar

Kazuo Takechi

Green Cross International

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge